Navigation Links
Business Guru Michael E. Gerber appointed to ReliantHeart Board of Directors

HOUSTON, TX (PRWEB) November 21, 2013

ReliantHeart, Inc., the manufacturer of the HeartAssist5® Ventricular Assist Device (VAD) has appointed to its Board of Directors Michael E. Gerber, writer of the best-selling book 'The E-Myth Revisited' and well-known legend of entrepreneurship.

INC. Magazine called Gerber “the World’s #1 Business Guru,” with his 40 years of experience addressing the needs of businesses owned primarily by people with technical skills but few business skills, and no place to go to get meaningful help. Over the years, Gerber’s companies have helped tens of thousands of business owners successfully transform their businesses into world-class operations.

Gerber created The Dreaming Room®, a training program that is held throughout the United States, Canada and the United Kingdom. Based on his experiences with entrepreneurs in these Dreaming Room events, along with the tens of thousands of clients Gerber has done business coaching with over the years, he authored 'Awakening the Entrepreneur Within.'

Gerber is also the best-selling author of 'The E-Myth Revisited,' co-authored several E-Myth industry-specific books, and 13 other business coaching books. The 'E-Myth Revisited,' has sold more than 5 million copies in 29 languages, and E-Myth methodology is taught in 118 universities worldwide.

According to Gerber, the core of the E-Myth is to work on the business, not in the business, in order to create the systems that allow ordinary people to produce extraordinary results, over and over again. The systems then allow the business to be continually improved through innovation, quantification and orchestration.

Gerber’s experience will contribute significantly to the ReliantHeart Board of Directors, as the company advances its revolutionary HeartAssist5® VAD, a powerful, implantable, electric pump designed to augment a failing human heart.

The HeartAssist5® has been proven effective in supporting blood circulation, reversing end-organ dysfunction and giving patients a much-improved quality of life as they await heart transplants. More than 12,000 patients worldwide have been supported by ventricular assist devices while awaiting transplant, however, the HeartAssist5® is the only VAD in the world that allows healthcare providers to monitor their patients remotely.

The HeartAssist5® System is currently being implanted in certified centers across Europe. ReliantHeart intends to enter a United States FDA approved clinical trial in 2014 to collect safety and effectiveness data. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
2. Introducing a New, Easy Way for Industrial Businesses to Join the Online Conversation
3. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
4. McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock
5. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
6. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
7. Animal Husbandry Equipment Market in United States: Business Report 2011
8. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
9. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
10. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
11. Launched, a Unique Life Science Business Networking Site
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - ... ... ... With ...
Breaking Biology News(10 mins):